Risk assessment

Cardiovascular Risk Assessment

Identification, stratification and mitigation of cardiovascular risk in adults accessing pharmacological and clinical weight management services

For Weight Loss ClinicRef BS-WEI-RA-001See a sample (PDF) →
£44.99
One-off purchase · no VAT · instant download
  • Instant download after checkout
  • Editable Microsoft Word (.docx)
  • Mapped to the CQC standards
  • Optional 3-monthly updates

What's inside

This risk assessment is fully drafted and structured, ready to brand and complete for your service. It covers:

  • 1. Scope and purpose
  • 2. Legal and regulatory framework
  • 3. Risk assessment methodology
  • 4. Hazards, controls and risk rating
  • 5. Action plan
  • 6. Monitoring and review
  • 7. Disclaimer

Legislation & standards it maps to

  • Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 - in particular Regulation 9 (Person-centred care), Regulation 12 (Safe care and treatment), Regulation 17 (Good governance) and Regulation 18 (Staffing)
  • Care Quality Commission (Registration) Regulations 2009
  • Health and Safety at Work etc. Act 1974 and the Management of Health and Safety at Work Regulations 1999
  • Human Medicines Regulations 2012 (as amended)
  • General Pharmaceutical Council Standards for Registered Pharmacies and the General Pharmaceutical Council Guidance for Registered Pharmacies Providing Pharmacy Services at a Distance, Including on the Internet (2022)
  • National Institute for Health and Care Excellence Clinical Guideline CG181 (Cardiovascular disease: risk assessment and reduction, including lipid modification) and National Institute for Health and Care Excellence Guideline NG246 (Overweight and obesity management, 2025)
  • Data Protection Act 2018 and the UK General Data Protection Regulation

Who it applies to

All clinical, prescribing, nursing, healthcare assistant, reception and governance staff involved in the assessment, prescribing, monitoring and review of patients within the weight loss clinic, including independent prescribers, supervising clinicians and locum/agency staff.

Glossary

Plain-English explanations of the technical terms and legislation used in this document.

Accident and emergency (A&E)
The hospital department that treats people with serious or life-threatening injuries and illnesses, often reached by calling 999.
Acute coronary syndrome
A sudden reduction of blood flow to the heart, including a heart attack and unstable angina, that needs emergency treatment.
Anaphylaxis
A severe, life-threatening allergic reaction needing immediate emergency treatment.
Anticoagulant
A medicine that reduces the blood's ability to clot, sometimes called a blood thinner.
Arrhythmia
An abnormal heart rhythm, where the heart beats too fast, too slow or irregularly.
Atrial fibrillation
A common irregular and often fast heart rhythm that can raise the risk of stroke.
Basic life support (BLS)
Emergency first aid, including chest compressions and rescue breaths, used to keep someone alive until further help arrives.
Blood pressure
The pressure of blood against the walls of the arteries, recorded as two numbers and measured in millimetres of mercury (mmHg).
Cardiovascular
Relating to the heart and blood vessels.
Care Quality Commission (CQC)
The independent regulator of health and social care services in England.
Contraindication
A specific reason a treatment or medicine should not be used because it could harm the patient.
Diuretic
A medicine, sometimes called a water tablet, that makes the body pass more urine and can affect the balance of salts in the blood.
Dose titration
Gradually adjusting the dose of a medicine, usually increasing it in steps, to reach the right level safely.
Duty of candour
The legal duty to be open and honest with a person and their family when something goes wrong with their care.
Dyslipidaemia
An unhealthy level of fats, such as cholesterol, in the blood.
Electrocardiogram (ECG)
A simple test that records the electrical activity of the heart to check its rhythm and function.
Electrolytes
Essential salts and minerals in the blood, such as sodium and potassium, that the body needs to work properly.
Fundamental standards
The minimum standards of safety and quality below which care must never fall.
Gastrointestinal
Relating to the stomach and intestines, the digestive system.
General practitioner (GP)
A doctor based in the community who provides general medical care and refers patients to other services when needed.
GIP/GLP-1 agonist (dual agonist)
A medicine that acts on two gut hormone pathways (GIP and GLP-1) to help control blood sugar and reduce appetite, for example tirzepatide.
GLP-1 receptor agonist
A medicine that mimics a natural gut hormone to reduce appetite and help with weight loss and blood sugar control, for example semaglutide or liraglutide.
Healthcare assistant (HCA)
A member of staff who supports nurses and clinicians with patient care tasks under supervision.
Heart failure
A long-term condition in which the heart cannot pump blood around the body as well as it should.
Hypertension
Persistently raised blood pressure, which increases the risk of heart attack, stroke and other harm.
Independent prescriber
A qualified health professional, such as a pharmacist or nurse, legally allowed to assess patients and prescribe medicines on their own responsibility.
Informed consent
Agreement to treatment given freely after the risks, benefits and alternatives have been clearly explained.
Likelihood
How probable it is that a particular harm will happen, given the controls already in place.
Medicines and Healthcare products Regulatory Agency (MHRA)
The UK body that regulates medicines and medical devices and issues safety alerts about them.
Medicines reconciliation
Checking and confirming the full, accurate list of medicines a patient is taking to avoid errors and harmful combinations.
Millimetres of mercury (mmHg)
The unit used to measure blood pressure.
National Institute for Health and Care Excellence (NICE)
The body that produces evidence-based guidance on treatments and care for use across health and social care.
Near miss
An event that could have caused harm but did not, by chance or because it was caught in time.
Nominated Individual
The senior person responsible to the regulator for supervising how a service is provided.
Obstructive sleep apnoea
A condition in which breathing repeatedly stops and starts during sleep because the airway becomes blocked.
Orlistat
A weight-loss medicine that reduces the amount of fat the body absorbs from food.
Palpitations
An awareness of the heartbeat, such as it feeling fast, fluttering or irregular.
QRISK3
A widely used calculator that estimates a person's risk of heart attack or stroke over the next ten years.
QT prolongation
A delay in the heart's electrical recovery, seen on an electrocardiogram, that can increase the risk of a dangerous heart rhythm.
Reasonably practicable
Doing what is sensible and proportionate to reduce a risk, weighing the effort and cost against the level of risk involved.
Red flag
A warning sign or symptom that may indicate a serious problem needing urgent assessment or action.
Registered Manager
The person registered with the regulator as responsible for the day-to-day running of a service.
Regulated activity
A type of care or treatment the law requires a provider to register with the regulator to deliver.
Residual risk
The level of risk that remains after the existing controls have been put in place.
Risk assessment
A structured check identifying what could cause harm and what is being done to prevent it.
Safeguarding
Protecting people's health, wellbeing and rights and keeping them safe from abuse, harm or neglect.
Safety-netting
Telling a patient clearly what to watch for and what to do, including when and how to seek urgent help, if their condition changes or worsens.
Severity
How serious the worst plausible outcome of a hazard would be.
Single assessment framework
The structure the regulator uses to judge a service, built around quality statements and five key questions (safe, effective, caring, responsive, well-led).
Statin
A medicine that lowers cholesterol to reduce the risk of heart attack and stroke.
Summary of Product Characteristics (SmPC)
The official document for a medicine that sets out how it should be prescribed and used safely.
Sympathomimetic
A substance that stimulates the body's 'fight or flight' system and can raise heart rate and blood pressure.
Tachyarrhythmia
An abnormally fast heart rhythm.
Type 2 diabetes
A common long-term condition in which blood sugar levels are too high because the body cannot use insulin properly.
Urea and electrolytes (U&E)
A common blood test that checks kidney function and the balance of salts in the blood.
Yellow Card scheme
The UK system for reporting suspected side effects of medicines and problems with medical devices to the Medicines and Healthcare products Regulatory Agency.

How it works

  1. Buy securely with Stripe - instant, no VAT, no account needed.
  2. Download your editable Word file from the link we email you straight away.
  3. Complete the placeholders for your service, then have it approved before use.
  4. Add the optional updates subscription and we keep it current as guidance changes.

Related documents

PolicyGLP-1 Prescribing Policy£54.99
PolicyCardiovascular Assessment Policy£54.99
PolicyPsychological Screening Policy£54.99
PolicyInformed Consent Policy£54.99

Need the whole set?

Buy the full Weight Loss Clinic pack and save versus buying documents individually.

View the Weight Loss Clinic pack